
Novo Opposes Pharma Tariffs, Urges Crackdown on Illicit Chinese Semaglutide
Novo Nordisk “strongly” urged the Department of Commerce not to impose tariffs on pharmaceutical products, citing the potential disruptions such a move could have on access to crucial medications. The Danish pharma made these assertions in a letter to the …